Revascular adds $3M to clear arteries
Revascular Therapeutics, maker of a device that helps doctors clear blockages in major arteries, has tacked on $3 million to a second round of funding, bringing its total to $11 million, reports VentureWire. The Sunnyvale, Calif., company hopes to add $1 million more to fully fund a study on its lead product.
Revascular’s device — which combines light and sound to guide physicians through vein-clearing procedures — is under testing in Europe expected to finish in… Continue Reading